Passage Bio, Inc. (PASG)

4.75 -0.29 (-5.75%) USD  |  NASDAQ  |  Sep 18, 16:00
4.70 -0.05 (-1.05%) After-Hours: 20:00
More

Passage Bio Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for PASG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
June 26, 2026 --
June 10, 2026 --
May 06, 2026 --
April 24, 2026 --
April 21, 2026 --
April 20, 2026 --
April 06, 2026 --
March 30, 2026 --
March 04, 2026 --
March 03, 2026 --
February 10, 2026 --
November 24, 2025 --
November 11, 2025 --
October 08, 2025 --
Date Value
August 13, 2025 --
June 24, 2025 --
June 23, 2025 --
May 19, 2025 --
May 15, 2025 --
May 13, 2025 --
March 04, 2025 --
November 29, 2024 --
August 08, 2024 --
August 01, 2024 --
May 14, 2024 --
March 04, 2024 --
February 23, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
ARS Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade